|
The new Merck (formerly Schering-Plough) makes medicines for a number of ailments, from stuffy noses and asthma to hypertension and arthritis. The pharmaceutical giant's top prescription drugs include asthma medication Singulair, anti-inflammatory Remicade, hypertension fighters Cozaar and Hyzaar, and cholesterol combatants Vytorin, Zetia, and Zocor. The company also makes animal health pharmaceuticals, as well as childhood and adult vaccines for such diseases as measles, mumps, hepatitis, and shingles. Its OTC drug and personal care offerings include Claritin allergy pills and Dr. Scholl's foot care products. The company completed a reverse merger with the old Merck in 2009 and took on the Merck name.
|
| | | Contact Information | |
Address: |
1 Merck Dr.
Whitehouse Station, NJ 08889-0100
| | Phone: | 908-423-1000 | | Fax: | 908-735-1253 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 18502.00 M | | Revenue Growth (1 yr): | 45.80% | | Employees (2008): | 51,000 | | Employee Growth (1 yr): | (-7.30%) |
|
|
Key People
| | • |
Chairman, President, and CEO:
Richard T. (Dick) Clark
| | • |
EVP and CFO:
Peter N. Kellogg
| | • |
Media Contact, Scientific Affairs, R&D, and Licensing and Pa:
Ian McConnell
|
|
|
